Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $1.42-$15.10 |
Market Cap | $540.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $1.1B |
Revenue Growth (YoY) | 8.6% |
Gross Profit (12 Mos) | $290.1M |
Diluted EPS | -$11.22 |
News
See moreYahoo Finance • 2 months ago
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
Yahoo Finance • 3 months ago
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
Yahoo Finance • 5 months ago
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Yahoo Finance • 7 months ago
Emergent BioSolutions Reports First Quarter 2024 Financial Results
About
CEO | Mr. Joseph C. Papa Jr. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 400 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,600 |
